McKesson Corporation (MCK)

MCK · Health Care · United States

McKesson Corporation (MCK) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 1.69 % in XUHL (msci-usa-health-care). Anyone holding one of these ETFs also owns a small indirect stake in McKesson Corporation.

Above-average ETF coverage: 20 of the 95 ETFs we cover hold McKesson Corporation, spread across 9 indices. That puts the stock in more ETFs than 82.9 % of the 4,334 stocks we cover.

Held in20 ETFs

Highest weight1.69 %

Indices9

SectorHealth Care

CountryUnited States

ISINUS58155Q1031

WKN893953

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date	+8.2 %	1 year	+28.0 %
1 month	+3.2 %	3 months	+13.8 %
Calendar year 2025	+43.9 %

52W

Data note 3

Measured in euros, McKesson Corporation returned +10.2 % year to date and +30.9 % over one year. The gap to the dollar figures above comes from the exchange rate alone: each daily price is converted at the ECB euro reference rate for the same day.

Data note 4

Risk metrics

Max drawdown-27.2 %

Volatility p.a.28.6 %

Data note 5

Below peak-10.9 %

Beta to S&P 500-0.27

Correlation to S&P 500-0.11

The close on Sep 16, 2026 was 10.9 % below the highest close since Aug 12, 2024, reached on Mar 3, 2026. Over the last 252 trading days, on days when the S&P 500 rose or fell 1 %, McKesson Corporation moved on average 0.27 % in the opposite direction. The correlation of -0.11 shows how reliable that average is: the broad market explained only a small share of the daily moves.

Data note 6

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Correlated with
Instrument	r	−1 … +1
Cencora Inc.	+0.75
Cardinal Health Inc.	+0.61
Arthur J. Gallagher & Co.	+0.58
Aon Plc Class A	+0.55
Erie Indemnity Company Class A	+0.54
Chubb Limited	+0.53
Astera Labs Inc.	-0.57
Corning Inc	-0.54
Teradyne Inc.	-0.52

Data note 7

Key financials

Latest reported fiscal year (FY2025, period end 2026-03-31) as filed with the SEC.

Revenue403.4 bn $

Net income4.8 bn $

Diluted EPS38.38 $

Net margin1.2 %

Gross margin3.6 %

Return on equity-366.9 %

Equity ratio-1.5 %

Revenue growth+12.4 %

Revenue and profit by fiscal year
Fiscal year	Revenue	Net income	Margin
FY2023	309.0	3.0	1.0 %
FY2024	359.1	3.3	0.9 %
FY2025	403.4	4.8	1.2 %

Data note 8

Held in these ETFs

Held in these ETFs
ETF	Index	Weight	per €1,000 in the ETF
XUHL / XUHC	msci-usa-health-care	1.69 %	€16.90
XDWH	msci-world-health-care	1.25 %	€12.50
SPFS	msci-world-health-care	1.25 %	€12.50
XDEB	msci-world-minimum-volatility	0.99 %	€9.90
SPYL / SPY5	sp500	0.16 %	€1.60
SXR8	sp500	0.16 %	€1.60
XD9U / XD9D	msci-usa	0.16 %	€1.60
SPYI / SPSA	msci-acwi-imi	0.14 %	€1.40
SWWD	msci-world	0.12 %	€1.20
EUNL	msci-world	0.12 %	€1.20
SPPW	msci-world	0.12 %	€1.20
XDWD / XDWL	msci-world	0.12 %	€1.20
WIMI	msci-world-imi	0.11 %	€1.10
IUSQ	msci-acwi	0.11 %	€1.10
SPYY	msci-acwi	0.10 %	€1.00

Data note 9

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to McKesson Corporation as of the fund's latest holdings list.

Weight in EUNL since 2019

Sep 30, 2019Sep 16, 2026

In EUNL, a fund tracking the MSCI World, McKesson Corporation had a weight of 0.06 % on Sep 30, 2019 and 0.12 % on Sep 16, 2026. Its share peaked at 0.14 % on Mar 31, 2026. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 10

How much McKesson Corporation overlaps with other holdings in a portfolio is shown by the Portfolio X-Ray and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as McKesson Corporation — the figure counts the ETFs holding both.

Data note 11

Key figures side by side

Key figures compared with stocks of similar ETF exposure
Stock	1 year	Volatility p.a.	Net margin	Revenue growth
McKesson Corporation	+28.0 %	28.6 %	1.2 %	+12.4 %
AbbVie	+21.4 %	26.9 %	6.9 %	+8.6 %
Abbott Laboratories	-22.9 %	24.1 %	14.7 %	+5.7 %
Cardinal Health	+56.7 %	26.4 %	0.7 %	-1.9 %
Cencora	+9.8 %	26.4 %	0.5 %	+9.3 %
Edwards Lifesciences Corporation	+18.9 %	25.1 %	17.7 %	+11.5 %
HCA Healthcare Inc	+7.7 %	29.1 %	9.0 %	+7.1 %
Eli Lilly and Company	+48.8 %	38.3 %	31.7 %	+44.7 %
Boston Scientific Corporation	-55.6 %	31.0 %	–	+19.9 %

Return and volatility from our daily closing prices in US dollars; margin and growth from the latest SEC annual filing. Fiscal years do not all end on the same date.